ArticlePharmacoEconomics2021

Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies.

Luis Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.